Publicações

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

AuthID
P-00W-G1F

Author(s)

Greco, C

Pares, O

Pimentel, N

Louro, V

Nunes, B

Kociolek, J

Stroom, J

Vieira, S

Mateus, D

Cardoso, MJ

Soares, A

Marques, J

Freitas, E

Coelho, G

Fuks, Z

Tipo de Documento

Article

Year published

2022

Publicado

in FRONTIERS IN ONCOLOGY, ISSN: 2234-943X

Volume: 12

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.3389/fonc.2022.863655

Pubmed: 35433469

SCOPUS: 2-s2.0-85128478927

Wos: WOS:000789127100001

Source Identifiers

ISSN: 2234-943X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase Ii Study

Links Úteis

Ajuda